Michael Steiner

Summary

Affiliation: University of Auckland
Country: New Zealand

Publications

  1. doi request reprint 14-3-3σ mediates G2-M arrest produced by 5-aza-2'-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells
    Michael Steiner
    Liggins Institute, Auckland University, Auckland, New Zealand
    Gynecol Oncol 127:231-40. 2012
  2. doi request reprint Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2
    Jian Zhong Tang
    Liggins Institute, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    Mol Cancer Ther 9:1697-708. 2010
  3. pmc Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells
    Arindam Banerjee
    Liggins Institute, University of Auckland, Auckland 1023, New Zealand
    J Biol Chem 287:42502-15. 2012
  4. doi request reprint Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells
    Nicola M Bougen
    The Liggins Institute, University of Auckland, Auckland, New Zealand
    Endocr Relat Cancer 19:625-44. 2012
  5. doi request reprint STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone
    Jian Zhong Tang
    Liggins Institute, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1142, New Zealand
    Endocrinology 151:4133-45. 2010
  6. doi request reprint Cell cycle regulation of human endometrial stromal cells during decidualization
    Philip C Logan
    The Liggins Institute, University of Auckland, Auckland, New Zealand
    Reprod Sci 19:883-94. 2012
  7. doi request reprint Epigenetic regulation of E-cadherin controls endometrial receptivity
    Fahimeh Rahnama
    Faculty of Medical and Health Sciences, National Research Centre for Growth, Development and the Liggins Institute, University of Auckland, Private Bag, Auckland, New Zealand
    Endocrinology 150:1466-72. 2009
  8. pmc Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24
    Vijay Pandey
    The Liggins Institute, Auckland, University of Auckland, Auckland, New Zealand
    Transl Oncol 3:218-29. 2010

Collaborators

Detail Information

Publications8

  1. doi request reprint 14-3-3σ mediates G2-M arrest produced by 5-aza-2'-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells
    Michael Steiner
    Liggins Institute, Auckland University, Auckland, New Zealand
    Gynecol Oncol 127:231-40. 2012
    ..To determine the effect of 5-aza-2'-deoxycytidine (DAC) on human endometrial carcinoma cell (HECC) oncogenicity and demonstrate a molecular mechanism by which DAC modulates HECC oncogenicity...
  2. doi request reprint Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2
    Jian Zhong Tang
    Liggins Institute, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
    Mol Cancer Ther 9:1697-708. 2010
    ..ARTN therefore mediates progression of NSCLC and may be a potential therapeutic target for NSCLC...
  3. pmc Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells
    Arindam Banerjee
    Liggins Institute, University of Auckland, Auckland 1023, New Zealand
    J Biol Chem 287:42502-15. 2012
    ..Increased expression of ARTN and the functional consequences thereof may be one common adaptive mechanism used by mammary carcinoma cells to promote cell survival and renewal in hostile tumor microenvironments...
  4. doi request reprint Autocrine human GH promotes radioresistance in mammary and endometrial carcinoma cells
    Nicola M Bougen
    The Liggins Institute, University of Auckland, Auckland, New Zealand
    Endocr Relat Cancer 19:625-44. 2012
    ..Functional antagonism of hGH, used in conjunction with radiotherapy, may therefore enhance treatment efficacy and improve the prognosis of patients with breast and endometrial cancer...
  5. doi request reprint STAT3alpha is oncogenic for endometrial carcinoma cells and mediates the oncogenic effects of autocrine human growth hormone
    Jian Zhong Tang
    Liggins Institute, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1142, New Zealand
    Endocrinology 151:4133-45. 2010
    ..STAT3alpha may therefore be a common mediator of oncogenic signaling pathways stimulating progression of EC...
  6. doi request reprint Cell cycle regulation of human endometrial stromal cells during decidualization
    Philip C Logan
    The Liggins Institute, University of Auckland, Auckland, New Zealand
    Reprod Sci 19:883-94. 2012
    ..In this study, we hypothesized that both the classic progestin treatment and DNA methylation inhibition would inhibit stromal cell proliferation and cell cycle transition...
  7. doi request reprint Epigenetic regulation of E-cadherin controls endometrial receptivity
    Fahimeh Rahnama
    Faculty of Medical and Health Sciences, National Research Centre for Growth, Development and the Liggins Institute, University of Auckland, Private Bag, Auckland, New Zealand
    Endocrinology 150:1466-72. 2009
    ..Therefore, we have provided evidence that E-cadherin plays an important role in uterine receptivity and that E-cadherin expression is epigenetically regulated in AN3-CA cells, suppressed by the combined actions of DNMT-1, -3A, and -3B...
  8. pmc Artemin Reduces Sensitivity to Doxorubicin and Paclitaxel in Endometrial Carcinoma Cells through Specific Regulation of CD24
    Vijay Pandey
    The Liggins Institute, Auckland, University of Auckland, Auckland, New Zealand
    Transl Oncol 3:218-29. 2010
    ..Functional inhibition of ARTN may therefore be considered as an adjuvant therapeutic approach to improve the response of endometrial carcinoma to specific chemotherapeutic agents...